Bisphosphonates in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bisphosphonates in breast cancer

Published:2014-05-20 Issue:4 Volume:137 Page:753-764
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Mathew Aju¹,Brufsky Adam²

Affiliation:

1. Division of Hematology and Oncology, University of Pittsburgh Cancer Institute; 5150 Center Avenue, UPMC Cancer Pavilion, Room 463 Pittsburgh PA

2. Division of Hematology and Oncology, University of Pittsburgh Cancer Institute; 300 Halket Street, Room 3524 Pittsburgh PA

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference55 articles.

1. American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer;Poznak;J Clin Oncol,2011

2. Practical guidance for the management of aromatase inhibitor-associated bone loss;Hadji;Ann Oncol,2008

3. Bisphosphonates and other bone agents for breast cancer;Wong;Cochrane Database Syst Rev,2012

4. Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro;der Pluijm;J Clin Invest,1996

5. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid;Wood;J Pharmacol Exp Ther,2002

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Repositioning for Ovarian Cancer Treatment: An Update;Anti-Cancer Agents in Medicinal Chemistry;2024-05

2. Enhancing the Oral Rehabilitation and Quality of Life of Bisphosphonate-Treated Patients: The Role of Dental Implants;Cureus;2023-10-07

3. The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment;Biomedicine & Pharmacotherapy;2023-05

4. Withaferin A inhibits breast cancer‐induced osteoclast differentiation;Molecular Carcinogenesis;2023-04-17

5. Clinical and sociodemographic risk factors associated with the development of second primary cancers among postmenopausal breast cancer survivors;Breast Cancer;2022-11-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3